Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.news-medical.net/news/20230118/The-efficacy-of-low-dose-fluvoxamine-compared-with-placebo-for-treating-mild-to-moderate-COVID-19-in-the-US.aspx
0
0
The efficacy of low-dose fluvoxamine compared with placebo for treating mild to moderate COVID-19 in the US - News-Medical.Net
1/18/23 at 3:46pm
Organization
News-Medical.Net
Authors
Details
53 words
Summarize
Drugs & Medications
Health Conditions
fluvoxamine
COVID
SARS-CoV
Researchers evaluated the efficacy of low-dosage fluvoxamine (50 mg two times a day) over 10 days in the management of mild and moderate-SARS-CoV-2 infections in the US.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...